Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04471493

Pediatric and Ambulatory Research in Infectious Diseases

Many ambulatory networks are mainly based on diagnoses made by first-line physicians not specifically trained to join the network. Here we aim to set up a surveillance network on pediatric infectious diseases with an investment in teaching with specific trainings of participating pediatricians, increasing in use of point of care tests, and automated data extraction from the computers of the pediatricians.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Otitis Bronchial Diseases Bronchiolitis Bronchitis Chickenpox DNA Virus Infections Digestive System Diseases Ear Diseases Gastroenteritis Gastrointestinal Diseases Herpesviridae Infections Infections Influenza Influenza, Human Lung Diseases Lung Diseases, Obstructive Orthomyxoviridae Infections Otorhinolaryngologic Diseases Pharyngeal Diseases Pharyngitis Pneumonia RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Stomatognathic Diseases Varicella Varicella Zoster Virus Infection Virus Diseases

Age range

1 day–16 year

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

107 pediatricians among the 1400 members of the French ambulatory pediatric association, AFPA (Association Française de Pédiatrie Ambulatoire) were involved in this survey.To belong to the PARI network, pediatricians have to use the same software, Axi5-Infansoft (developed by CompuGroup Medical, Nanterre, France) for electronic medical record of children. The pediatricians were trained to the use of point of care tests and to the infectious diagnoses (otitis, pharyngitis, varicella, bronchiolitis, influenza, pneumonia, etc..). The study population consisted of all children under 16 years of age from the patient population for which an infectious disease was diagnosed.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children under 16 years of age with at least one infectious disease among:
  • pharyngitis
  • otitis
  • pneumonia
  • influenza
  • bronchiolitisz
  • varicella
  • gastroenteritis
  • enterovirus disease
  • bordetella pertussis disease
  • using the same same software, Axi5-Infansoft (developed by CompuGroup Medical, Nanterre, France)

Exclusion criteria

  • parental refusal

Treatment and study plan

Primary outcomes

  1. Evaluation of the number of infectious diseases

    Time frame: 5 years

    proportion of children under 16 years, with infectious disease

Secondary outcomes

  1. Evaluation of the use of point of care tests

    Time frame: 5 years

    Proportion of use of point of care tests and positivity rate according to the infectious diseases

  2. Evaluation of the antibiotic treatments

    Time frame: 5 years

    Proportion of each antibiotic treatments according to the infectious diseases

Study contacts

Contact information is provided by the study sponsor or research team.

Corinne LEVY, MD

CONTACT

[email protected]

0033148850404

Stéphane Béchet, MSc

CONTACT

[email protected]

0033148850404

Sponsors and collaborators

Lead sponsor

Association Clinique Thérapeutique Infantile du val de Marne

Other

Collaborators

  • AFPA (Association Française de Pédiatrie Ambulatoire)
  • GlaxoSmithKline
  • Merck Sharp & Dohme LLC
  • Pfizer
  • Sanofi

Registry information

Official study title

Real Time Surveillance of Pediatric Infectious Diseases in French Ambulatory Care: PARI Study

Acronym: PARI

Important dates

Study start
2017
Primary completion
2030
Study completion
2030
First posted
Jul 15, 2020
Registry last updated
Feb 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.